UNRESECTABLE OR METASTATIC CUTANEOUS MELANOMA
Clinical trials for UNRESECTABLE OR METASTATIC CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE OR METASTATIC CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE OR METASTATIC CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat melanoma
Disease control Recruiting nowThis study tests a new treatment made from donor immune cells (CAR-NK cells) that are designed to attack two targets on melanoma cells. It is for adults with advanced melanoma that has spread or cannot be removed and has not responded to standard therapies. The goal is to find a …
Matched conditions: UNRESECTABLE OR METASTATIC CUTANEOUS MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill combo aims to fight advanced cancers that stopped responding to prior therapies
Disease control Recruiting nowThis study tests two oral drugs, AMXT 1501 and DFMO, given alongside standard treatments for people with advanced solid tumors (breast cancer or melanoma) that have worsened after prior therapies. The goal is to find a safe dose and see if the combination helps shrink tumors or s…
Matched conditions: UNRESECTABLE OR METASTATIC CUTANEOUS MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Aminex Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC